| Kaduk, James A.; Dosen, Anja; Blanton, Tom N. (2025). Crystal structure of ethynodiol diacetate, C
24
H
32
O
4
. Powder Diffraction , 1-6. 10.1017/s0885715625100729. |
BXDS-WLE |
Peer-Reviewed Article |
Health |
| Kaduk, James; Dosen, Anja; Blanton, Tom (2025). Crystal structure of anisomycin, C
14
H
19
NO
4
. Powder Diffraction , 1-6. 10.1017/s0885715625100791. |
BXDS-WLE |
Peer-Reviewed Article |
Health |
| Kaduk, James A.; Dosen, Anja; Blanton, Tom (2025). A proposed crystal structure of fruquintinib Form I, C21H19N3O5. Powder Diffraction , 1-7. 10.1017/s0885715625100808. |
BXDS-WLE |
Peer-Reviewed Article |
Health |
| Kaduk, James A.; Dosen, Anja; Blanton, Thomas (2025). Crystal structure of sparsentan, C32H40N4O5S. Powder Diffraction 40(2) , 157-161. 10.1017/s0885715625000132. |
BXDS-WLE |
Peer-Reviewed Article |
Health |
| Kaduk, James A.; Dosen, Anja; Blanton, Tom N. (2025). Crystal structure of trametinib dimethyl sulfoxide, C26H23FIN5O4(C2H6OS). Powder Diffraction 40(2) , 162-167. 10.1017/s0885715625000168. |
BXDS-WLE |
Peer-Reviewed Article |
Health |
| Kaduk, James A.; Dosen, Anja; Blanton, Tom N. (2025). Crystal structure of aprocitentan Form A, C16H14Br2N6O4S. Powder Diffraction 40(2) , 168-174. 10.1017/s088571562500017x. |
BXDS-WLE |
Peer-Reviewed Article |
Health |
| Kaduk, James A.; Dosen, Anja; Blanton, Thomas N. (2025). Crystal structure of flumethasone, C22H28F2O5. Powder Diffraction , 1-6. 10.1017/s0885715625000120. |
BXDS-WLE |
Peer-Reviewed Article |
Health |
| Kaduk, James A.; Dosen, Anja; Blanton, Thomas N. (2025). Crystal structure of diroximel fumarate, C11H13NO6. Powder Diffraction , 1-6. 10.1017/s0885715625000119. |
BXDS-WLE |
Peer-Reviewed Article |
Health |
| Kaduk, James A.; Dosen, Anja; Blanton, Thomas N. (2025). Crystal structure of etrasimod, C26H26F3NO3. Powder Diffraction , 1-6. 10.1017/s0885715625000107. |
BXDS-WLE |
Peer-Reviewed Article |
Health |
| Kaduk, James A.; Dosen, Anja; Blanton, Thomas N. (2024). Crystal structure of racemic benserazide hydrochloride Form I, C10H16N3O5Cl. Powder Diffraction , 1-7. 10.1017/s0885715624000496. |
BXDS-WLE |
Peer-Reviewed Article |
Health |
| Kaduk, James A.; Dosen, Anja; Blanton, Thomas N. (2024). Crystal structure of gepirone, C19H29N5O2. Powder Diffraction , 1-6. 10.1017/s0885715624000514. |
BXDS-WLE |
Peer-Reviewed Article |
Health |
| Diedrich, Camila; Zittlau, Isabella C.; Khalil, Najeh M.; Leontowich, Adam F. G.; Freitas, Rilton A. de et al. (2023). Optimized Chitosan-Based Nanoemulsion Improves Luteolin Release. Pharmaceutics 15(6) , 1592. 10.3390/pharmaceutics15061592. |
BXDS-WLE |
Peer-Reviewed Article |
Health |
| James, Ashley K.; Dolgova, Natalia V.; Nehzati, Susan; Korbas, Malgorzata; Cotelesage, Julien J. H. et al. (2022). Molecular Fates of Organometallic Mercury in Human Brain. ACS Chemical Neuroscience 13(12) , 1756-1768. 10.1021/acschemneuro.2c00166. |
CLS-APS |
Peer-Reviewed Article |
Health |
| Summers, Kelly L; Dolgova, Natalia V; Gagnon, Kenneth B; Sopasis, George J; James, Ashley K et al. (2020). PBT2 acts through a different mechanism of action than other 8-hydroxyquinolines: an X-ray fluorescence imaging study. Metallomics 12(12) , 1979-1994. 10.1039/d0mt00222d. |
CLS-APS |
Peer-Reviewed Article |
Health |
| Simpson, R.; Varney, T. L.; Swanston, T.; Coulthard, I.; Cooper, D. M. L. et al. (2019). Investigating Past Lead Exposure in Bioarchaeological Remains with Synchrotron X-ray Fluorescence and Absorption Spectroscopy. Synchrotron Radiation News 32(6) , 11-16. 10.1080/08940886.2019.1680209. |
CLS-APS |
Peer-Reviewed Article |
Health |